Patient 21 is a healthtech company that aims to empower patients and doctors to make better decisions by leveraging data.
Patient 21 has raised $76.0M in total funding. The most recent round was Series C. The last funding was announced in May 2023.
Patient 21's investors include Pitango VC, Target Global, Eight Roads Ventures, Piton Capital, PICO Venture Partners.
Patient 21 is headquartered in Berlin, Germany.
Patient 21 is a healthtech company that aims to empower patients and doctors to make better decisions by leveraging data.
Patient 21 is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Patient 21 — Funding & Investors." VCBacked, May 22, 2023, https://www.vcbacked.co/company/patient-21. Accessed August 14, 2026.
VCBacked. (2023). Patient 21 — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/patient-21
{{cite web |title=Patient 21 — Funding & Investors |url=https://www.vcbacked.co/company/patient-21 |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated